Anondita Medicare Limited
NNSE:ANONDITA994.00
INR
+13.55
(+1.38%)
ISIN
INE0VTV01012
Return %
Stock
S&P 500
1Y
122.25
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Semi-annual Revenue
FRC
•
in mil. unless spec.Semi-annual Earnings Per Share
FRC
•
in mil. unless spec.Semi-annual Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Anupam Ghosh
- Sector
- Producer manufacturing
- Industry
- Miscellaneous manufacturing
- Address
- Noida India
- IPO Date
- Sep 1, 2025
- Website
- anonditamedicare.com
- Similar Companies
- Business
- Anondita Medicare Limited is an Indian healthcare and medical consumables company primarily engaged in the manufacturing, marketing, and distribution of contraceptives, sexual wellness products, and diagnostic solutions. The company operates through two primary commercial channels, comprising proprietary branded consumer products and institutional original equipment manufacturing (OEM) contract services. Its core product and service portfolio includes natural rubber latex male condoms marketed under the flagship brand Cobra, offered in multiple textures, shapes, and flavored formulations including strawberry, chocolate, mint, butterscotch, coffee, and bubblegum; Cobra female condoms engineered for barrier protection and reproductive wellness; Cobra Smooth lubricating gels and intimate wellness formulations; Cobra premium personal care body deodorants; Cobra Shubh Samachar rapid diagnostic pregnancy test kits; healthcare consumables, including surgical and examination gloves; and specialized contract manufacturing, institutional packaging, and quality testing services for third-party pharmaceutical entities and public health programs. Founded in 1999 as Anondita Healthcare and restructured into Anondita Medicare Limited in March 2024, the company maintains its registered office in New Delhi, India, with corporate operations and an automated production facility located in Noida, Uttar Pradesh, India. The company distributes its products domestically across retail networks and government healthcare channels, while exporting to international markets across Africa, South America, Southeast Asia, and the Middle East, including South Africa, Brazil, Kenya, Uzbekistan, Nepal, Cuba, and the United Arab Emirates. In recent corporate developments, the company consolidated its operating assets into Anondita Medicare Limited in 2024, successfully completed an Initial Public Offering on the NSE Emerge platform in August 2025, broadened its product line to introduce female condoms, diagnostic test kits, and personal care products, secured an international export contract valued at approximately INR 43.14 crore under the South African government procurement program in mid-2026, and was designated as the lowest bidder (L1) by the Central Medical Services Society under the Ministry of Health and Family Welfare in late 2026 to supply over 80 million condoms for India's national family planning initiative.